Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6467)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2023 (publication date) through Oct 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li N, Zhu QX, Li GZ, Wang T, Zhou H. Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1α and inhibiting the RhoA/ROCK pathway. World J Diabetes 2023; 14(12): 1862-1876 [PMID: 38222788 DOI: 10.4239/wjd.v14.i12.1862] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i12/1862.htm |
| Number | Citing Articles |
| 1 |
Loredana N. Ionică, Adina V. Lința, Alina D. Bătrîn, Iasmina M. Hâncu, Bogdan M. Lolescu, Maria D. Dănilă, Lucian Petrescu, Ioana M. Mozoș, Adrian Sturza, Danina M. Muntean. The Off-Target Cardioprotective Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors: An Overview. International Journal of Molecular Sciences 2024; 25(14): 7711 doi: 10.3390/ijms25147711
|
| 2 |
Yifeng Gao, En Li, Fang Li, Ying Cui, Qi Shu, Yan Zhang, Lijuan Kong, Han Li, Xiaoyu Yang. Dapagliflozin alleviates mitochondrial damage in the myocardium under diabetic conditions by targeting sortilin. Cellular and Molecular Life Sciences 2025; 82(1) doi: 10.1007/s00018-025-05793-8
|
| 3 |
Qiang Fan, Yabo Wang, Qi An, Yunfei Ling. Right ventricular dysfunction following surgical repair of tetralogy of Fallot: Molecular pathways and therapeutic prospects. Biomedicine & Pharmacotherapy 2025; 184: 117924 doi: 10.1016/j.biopha.2025.117924
|
| 4 |
Teodora Mateoc, Andrei-Luca Dumitrascu, Corina Flangea, Daniela Puscasiu, Tania Vlad, Roxana Popescu, Cristina Marina, Daliborca-Cristina Vlad. SGLT2 Inhibitors: From Structure–Effect Relationship to Pharmacological Response. International Journal of Molecular Sciences 2025; 26(14): 6937 doi: 10.3390/ijms26146937
|
| 5 |
Yanling Chen, Xun Liu, Yixuan Liu, Yujia Li, Dingxiang Li, Zhigang Mei, Yihui Deng. Mitochondrial quality control in diabetes mellitus and complications: molecular mechanisms and therapeutic strategies. Cell Death & Disease 2025; 16(1) doi: 10.1038/s41419-025-07936-y
|
| 6 |
Elina Khattab, Michaelia Kyriakou, Elena Leonidou, Stefanos Sokratous, Angeliki Mouzarou, Michael M. Myrianthefs, Nikolaos P. E. Kadoglou. Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives. Pharmaceuticals 2025; 18(1): 134 doi: 10.3390/ph18010134
|
| 7 |
Jinyan Chen, Kexin Zhang, Xiao Yu, Jiayi Ren, Chengxia Kan, Sufang Sheng, Fang Han, Yang Zhang, Jian Chen, Xiaodong Sun. Flavonoids in Metabolic Disease: A Narrative Review of Mechanisms and Therapeutic Potential. Phytotherapy Research 2025; doi: 10.1002/ptr.70107
|
| 8 |
Mina Y. George, Mohamed S. Dabour, Eman Rashad, Beshay N. Zordoky. Empagliflozin Alleviates Carfilzomib-Induced Cardiotoxicity in Mice by Modulating Oxidative Stress, Inflammatory Response, Endoplasmic Reticulum Stress, and Autophagy. Antioxidants 2024; 13(6): 671 doi: 10.3390/antiox13060671
|
| 9 |
Xinxin Liu, Yingqi Ma, Xuefeng Wang, Xiaowen Zhang, Chen Shen, Youzhu Su, Xing Chang, Hao Zhou, Jian-Ping Liu. Cross-regulatory mechanisms linking ferroptosis, epigenetics, and circadian rhythm to mitochondrial quality control in diabetic cardiomyopathy. Journal of Advanced Research 2025; doi: 10.1016/j.jare.2025.09.046
|
| 10 |
Arwa Mithaiwala, Angel Godad. Exploring Hippo YAP/TAZ Signaling: A Novel Avenue for Cardiovascular Disorders. Cell Biology International 2025; 49(9): 1079 doi: 10.1002/cbin.70052
|
| 11 |
Ke-Xin Zhang, Cheng-Xia Kan, Fang Han, Jing-Wen Zhang, Xiao-Dong Sun. Elucidating the cardioprotective mechanisms of sodium-glucose cotransporter-2 inhibitors beyond glycemic control. World Journal of Diabetes 2024; 15(2): 137-141 doi: 10.4239/wjd.v15.i2.137
Abstract(784) |
Core Tip(720) |
Full Article(HTML)(2696)
|
Full Article with Cover (PDF)-996K(167)
|
Full Article (Word)-280K(20)
|
Audio-7845K(5)
|
Peer-Review Report-194K(117)
|
Answering Reviewers-179K(106)
|
Full Article (PDF)-656K(288)
|
Full Article (XML)-80K(144)
|
Times Cited (1)
|
Total Visits (7442)
|
Open
|
| 12 |
Sachin Dhiman, Sanchit Dhankhar, Anjali Garg, Manni Rohilla, Monika Saini, Thakur Gurjeet Singh, Samrat Chauhan, Samy Selim, Soad K. Al Jaouni, Sabina Yasmin, Naseem Begum, Aziza Alshahrani, Mohammad Yousuf Ansari. Mechanistic insights and therapeutic potential of astilbin and apigenin in diabetic cardiomyopathy. Heliyon 2024; 10(21): e39996 doi: 10.1016/j.heliyon.2024.e39996
|
| 13 |
Nada A. Elbaik, Shimaa M. Elshazly, Atef El-Gharbawy, Mahmoud H. Elbatreek. Agomelatine and empagliflozin synergistically protect against diabetic cardiomyopathy via nrf2/HO-1 signaling. European Journal of Pharmacology 2025; 1005: 178054 doi: 10.1016/j.ejphar.2025.178054
|
| 14 |
Maja Muric, Ivan Srejovic, Jovana Novakovic, Vladimir Zivkovic, Jovana Joksimovic Jovic, Jasmina Sretenovic, Marina Nikolic, Nevena Lazarevic, Marijana Andjic, Aleksandar Kocovic, Jovana Jakovljevic Uzelac, Sergey Bolevich, Vladimir Jakovljevic. The Combined Empagliflozin and Sacubitril/Valsartan Therapy Attenuates Isoproterenol-Induced Heart Failure in Rats: Functional, Molecular, and Structural Insights. Cardiovascular Drugs and Therapy 2025; doi: 10.1007/s10557-025-07675-4
|
| 15 |
Xiangling Duan, Xiaomeng Zhang, Bao Sun. The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02750-4
|
| 16 |
Betul Rabia Erdogan, Ebru Arioglu-Inan. SGLT2 inhibitors: how do they affect the cardiac cells. Molecular and Cellular Biochemistry 2025; 480(3): 1359 doi: 10.1007/s11010-024-05084-z
|